SYNTHETIC HUMANIZED LLAMA NANOBODY LIBRARY AND USE THEREOF TO IDENTIFY
SARS-COV-2 NEUTRALIZING ANTIBODIES
US Application 18/692,570
Filed on 2024-03-15
Filed on 2024-03-15
SYNTHETIC HUMANIZED LLAMA NANOBODY LIBRARY AND USE THEREOF TO IDENTIFY
SYNTHETIC HUMANIZED LLAMA NANOBODY LIBRARY AND USE THEREOF TO IDENTIFY SARS-COV-2 NEUTRALIZING ANTIBODIES
South Korea
10-2024-7012300
Filed on 2024-04-12
10-2024-7012300
Filed on 2024-04-12
SYNTHETIC HUMANIZED LLAMA NANOBODY LIBRARY AND USE THEREOF TO IDENTIFY SARS-COV-2 NEUTRALIZING ANTIBODIES
Australia
2022345251
Filed on 2024-03-08
2022345251
Filed on 2024-03-08
SYNTHETIC HUMANIZED LLAMA NANOBODY LIBRARY AND USE THEREOF TO IDENTIFY SARS-COV-2 NEUTRALIZING ANTIBODIES
Canada
3232223
Filed on 2024-03-11
3232223
Filed on 2024-03-11
SYNTHETIC HUMANIZED LLAMA NANOBODY LIBRARY AND USE THEREOF TO IDENTIFY SARS-COV-2 NEUTRALIZING ANTIBODIES
Japan
2024-516630
Filed on 2024-03-14
2024-516630
Filed on 2024-03-14
Improved CRISPR Therapy
US Application 17/049,980
Filed on 2020-10-23
Filed on 2020-10-23
Quantum Dot Conjugated Virus Spike Protein For Cell-based Bio-sensing Systems And Drug Screening
US Application 17/389,645
Filed on 2021-07-30
Filed on 2021-07-30
QUANTUM DOT CONJUGATED VIRUS SPIKE PROTEIN FOR CELL-BASED BIO-SENSING SYSTEMS AND DRUG SCREENING
Patent Cooperation Treaty
PCT/US2021/043846
Filed on 2021-07-30
PCT/US2021/043846
Filed on 2021-07-30
CRYSTAL FORMS AND METHODS OF SYNTHESIS OF (2R, 6R)-HYDROXYNORKETAMINE AND (2S, 6S)-HYDROXYNORKETAMINE
Canada
3228060
Filed on 2024-02-02
3228060
Filed on 2024-02-02